Within the broad spectrum of atrial fibrillation (AF) symptomatology, there is a striking subset of patients with predominant or even solitary nocturnal onset of the arrhythmia. This review covers AF with nocturnal onset, with the aim of defining this distinctive subgroup among patients with AF. A periodicity analysis is provided showing a clear increased onset between 10:00 pm and 7:00 am. Multiple interacting mechanisms are discussed, such as circadian modulation of electrophysiological properties, vagal tone, and sleep disorders, as well as the potential interaction and synergism between these factors, to provide a better understanding of this clinical entity. Lastly, potential therapeutic targets for AF with nocturnal onset are addressed such as upstream therapy for underlying comorbidities, type of drug and timing of drug administration and pulmonary vein isolation, ablation of the ganglionated plexus, and autonomic nervous system modulation. Understanding the underlying AF mechanisms in the individual patient with nocturnal onset will contribute to patient-specific therapy.
Keyphrases
- atrial fibrillation
- catheter ablation
- blood pressure
- obstructive sleep apnea
- sleep quality
- left atrial
- oral anticoagulants
- sleep apnea
- direct oral anticoagulants
- left atrial appendage
- heart failure
- drug administration
- emergency department
- depressive symptoms
- physical activity
- particulate matter
- case report
- randomized controlled trial
- heavy metals
- mesenchymal stem cells
- climate change
- acute coronary syndrome
- coronary artery disease
- left ventricular
- ultrasound guided
- replacement therapy